Arbutus Biopharma CorporationABUSNASDAQ
LOADING
|||
ROIC: Returns Declining
Strong compound growth.
Left:
||||
Return on invested capital
Latest
-65.47%
Near historical average
Average (9y)
-62.21%
Historical baseline
Range
High:-11.53%
Low:-145.52%
CAGR
+21.3%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | -65.47% | -2.5% |
| 2023 | -63.84% | -58.9% |
| 2022 | -40.17% | -5.8% |
| 2021 | -37.97% | +16.0% |
| 2020 | -45.19% | +66.7% |
| 2019 | -135.60% | -251.8% |
| 2018 | -38.54% | -0.8% |
| 2017 | -38.22% | +73.7% |
| 2016 | -145.52% | -1162.2% |
| 2015 | -11.53% | - |